NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Frank SA. Dynamics of Cancer: Incidence, Inheritance, and Evolution. Princeton (NJ): Princeton University Press; 2007.

Cover of Dynamics of Cancer

Dynamics of Cancer: Incidence, Inheritance, and Evolution.

Show details


  1. Adami, H. O., Hunter, D., and Trichopoulos, D., eds. 2002. Textbook of Cancer Epidemiology, Vol. 33 of Monographs in Epidemiology and Biostatistics. Oxford University Press, New York.
  2. Ames B. N., Gold L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990;249:970–971. [PubMed: 2136249]
  3. Anderson, D. E. 1970. Genetic varieties of neoplasia. In Genetic Concepts and Neoplasia: Proceedings of the 23rd Symposium on Fundamental Cancer Research, pp. 85–104. Williams & Wilkins, Baltimore.
  4. Andreassi M. G., Botto N., Colombo M. G., Biagini A., Clerico A. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases? Environmental and Molecular Mutagenesis. 2000;35:265–269. [PubMed: 10861945]
  5. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. British Journal of Cancer. 2000;83:1301–1308. [PMC free article: PMC2408797] [PubMed: 11044354]
  6. Armakolas A., Klar A. J. Cell type regulates selective segregation of mouse chromosome 7 DNA strands in mitosis. Science. 2006;311:1146–1149. [PubMed: 16497932]
  7. Armitage P. A note on the time-homogeneous birth process. Journal of the Royal Statistical Society, Series B (Methodological) 1953;15:90–91.
  8. Armitage P., Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. British Journal of Cancer. 1954;8:1–12. [PMC free article: PMC2007940] [PubMed: 13172380]
  9. Armitage P., Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. British Journal of Cancer. 1957;11:161–169. [PMC free article: PMC2073730] [PubMed: 13460138]
  10. Armitage, P., and Doll, R. 1961. Stochastic models for carcinogenesis. In Neyman, J., ed., Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, pp. 19–38. University of California Press, Berkeley.
  11. Armstrong B., Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. International Journal of Cancer. 1975;15:617–631. [PubMed: 1140864]
  12. Ashley D. J. Colonic cancer arising in polyposis coli. Journal of Medical Genetics. 1969a;6:376–378. [PMC free article: PMC1468792] [PubMed: 5365944]
  13. Ashley D. J. The two "hit" and multiple "hit" theories of carcinogenesis. British Journal of Cancer. 1969b;23:313–328. [PMC free article: PMC2008269] [PubMed: 5788039]
  14. Ayabe T., Satchell D. P., Wilson C. L., Parks W. C., Selsted M. E., Ouellette A. J. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nature Immunology. 2000;1:113–118. [PubMed: 11248802]
  15. Bach S. P., Renehan A. G., Potten C. S. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis. 2000;21:469–476. [PubMed: 10688867]
  16. Backvall H., Asplund A., Gustafsson A., Sivertsson A., Lundeberg J., Ponten F. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2005;571:65–79. [PubMed: 15748639]
  17. Bahar R., Hartmann C. H., Rodriguez K. A., Denny A. D., Busuttil R. A., Dolle M. E., Calder R. B., Chisholm G. B., Pollock B. H., Klein C. A., Vijg J. Increased cell-to-cell variation in gene expression in ageing mouse heart. Nature. 2006;441:1011–1014. [PubMed: 16791200]
  18. Bapat, S. A. 2006. Evolution of cancer stem cells. Seminars in Cancer Biology [doi:10.1016/j.semcancer.2006.05.001]. [PubMed: 16787749]
  19. Barbacid M. ras genes. Annual Review of Biochemistry. 1987;56:779–827. [PubMed: 3304147]
  20. Barton N. H., Keightley P. D. Understanding quantitative genetic variation. Nature Reviews Genetics. 2002;3:11–21. [PubMed: 11823787]
  21. Beckman R. A., Loeb L. A. Genetic instability in cancer: theory and experiment. Seminars in Cancer Biology. 2005;15:423–435. [PubMed: 16043359]
  22. Berenblum I. The cocarcinogenic action of croton resin. Cancer Research. 1941;1:44–48.
  23. Berenblum I., Shubik P. A new, quantitative approach to the study of stages of chemical carcinogenesis in the mouse's skin. British Journal of Cancer. 1947a;1:383–391. [PMC free article: PMC2007527] [PubMed: 18906316]
  24. Berenblum I., Shubik P. The role of croton oil applications associated with a single painting of a carcinogen in tumour induction of the mouse's skin. British Journal of Cancer. 1947b;1:379–382. [PMC free article: PMC2007538] [PubMed: 18906315]
  25. Berenblum I., Shubik P. The persistence of latent tumour cells induced in the mouse's skin by a single application of 9:10-dimethyl-1:2-benzanthracene. British Journal of Cancer. 1949;3:384–386. [PMC free article: PMC2007653] [PubMed: 15394415]
  26. Bernstein C., Bernstein H., Payne C. M., Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutation Research. 2002;511:145–178. [PubMed: 12052432]
  27. Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. Journal of the National Cancer Institute. 2000;92:874–897. [PubMed: 10841823]
  28. Boland, C. R. 2002. Heredity nonpolyposis colorectal cancer (HNPCC). In Vogelstein, B., and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd edition)., pp. 307–321. McGraw-Hill, New York.
  29. Bond G. L., Hu W., Bond E. E., Robins H., Lutzker S. G., Arva N. C., Bargonetti J., Bartel F., Taubert H., Wuerl P., Onel K., Yip L., Hwang S. J., Strong L. C., Lozano G., Levine A. J. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 2004;119:591–602. [PubMed: 15550242]
  30. Bonsing B. A., Corver W. E., Fleuren G. J., Cleton-Jansen A. M., Devilee P., Cornelisse C. J. Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases. Genes, Chromosomes and Cancer. 2000;28:173–183. [PubMed: 10825002]
  31. Boon L. M., Brouillard P., Irrthum A., Karttunen L., Warman M. L., Rudolph R., Mulliken J. B., Olsen B. R., Vikkula M. A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21–22. American Journal of Human Genetics. 1999;65:125–133. [PMC free article: PMC1378082] [PubMed: 10364524]
  32. Boveri, T. 1914. Zur Frage der Entstehung maligner Tumoren. Fischer, Jena.
  33. Boveri, T. 1929. The Origin of Malignant Tumors. Williams and Wilkins, Baltimore.
  34. Braakhuis B. J., Leemans C. R., Brakenhoff R. H. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Seminars in Cancer Biology. 2005;15:113–120. [PubMed: 15652456]
  35. Braakhuis B. J., Tabor M. P., Kummer J. A., Leemans C. R., Brakenhoff R. H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Research. 2003;63:1727–1730. [PubMed: 12702551]
  36. Bradford G. B., Williams B., Rossi R., Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Experimental Hematology. 1997;25:445–453. [PubMed: 9168066]
  37. Brash D. E. Roles of the transcription factor p53 in keratinocyte carcinomas. British Journal of Dermatology. 2006;154(Suppl 1):8–10. [PubMed: 16712710]
  38. Breivik J., Gaudernack G. Carcinogenesis and natural selection: a new perspective to the genetics and epigenetics of colorectal cancer. Advances in Cancer Research. 1999a;76:187–212. [PubMed: 10218102]
  39. Breivik J., Gaudernack G. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Seminars in Cancer Biology. 1999b;9:245–254. [PubMed: 10448112]
  40. Brouillard P., Boon L. M., Mulliken J. B., Enjolras O., Ghassibe M., Warman M. L., Tan O. T., Olsen B. R., Vikkula M. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas") American Journal of Human Genetics. 2002;70:866–874. [PMC free article: PMC379115] [PubMed: 11845407]
  41. Brouillard P., Ghassibe M., Penington A., Boon L. M., Dompmartin A., Temple I. K., Cordisco M., Adams D., Piette F., Harper J. I., Syed S., Boralevi F., Taieb A., Danda S., Baselga E., Enjolras O., Mulliken J. B., Vikkula M. Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect. Journal of Medical Genetics. 2005;42:e13. [PMC free article: PMC1735996] [PubMed: 15689436]
  42. Brouillard P., Vikkula M. Vascular malformations: localized defects in vascular morphogenesis. Clinical Genetics. 2003;63:340–351. [PubMed: 12752563]
  43. Brown C. C., Chu K. C. Use of multistage models to infer stage affected by carcinogenic exposure: example of lung cancer and cigarette smoking. Journal of Chronic Diseases. 1987;40(Suppl 2):171S–179S. [PubMed: 3667864]
  44. Brown K., Buchmann A., Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:538–542. [PMC free article: PMC53300] [PubMed: 2105486]
  45. Brown K., Burns P. A., Balmain A. Transgenic approaches to understanding the mechanisms of chemical carcinogenesis in mouse skin. Toxicology Letters. 1995;82–83:123–130. [PubMed: 8597039]
  46. Buermeyer A. B., Deschenes S. M., Baker S. M., Liskay R. M. Mammalian DNA mismatch repair. Annual Review of Genetics. 1999;33:533–564. [PubMed: 10690417]
  47. Burch P. R. Human cancer: Mendelian inheritance or vertical transmission? Nature. 1963;197:1042–1045. [PubMed: 14016899]
  48. Burch P. R. Genetic carrier frequency for lung cancer. Nature. 1964;202:711–712. [PubMed: 14190052]
  49. Burdette W. J. The significance of mutation in relation to the origin of tumors: a review. Cancer Research. 1955;15:201–226. [PubMed: 14379154]
  50. Burns P. A., Kemp C. J., Gannon J. V., Lane D. P., Bremner R., Balmain A. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene. 1991;6:2363–2369. [PubMed: 1766680]
  51. Buss, L. W. 1987. The Evolution of Individuality. Princeton University Press, Princeton, NJ.
  52. Cairns J. Mutation selection and the natural history of cancer. Nature. 1975;255:197–200. [PubMed: 1143315]
  53. Cairns, J. 1978. Cancer: Science and Society. W. H. Freeman, San Francisco.
  54. Cairns, J. 1997. Matters of Life and Death. Princeton University Press, Princeton, NJ.
  55. Cairns J. Mutation and cancer: the antecedents to our studies of adaptive mutation. Genetics. 1998;148:1433–1440. [PMC free article: PMC1460072] [PubMed: 9560363]
  56. Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:10567–10570. [PMC free article: PMC124976] [PubMed: 12149477]
  57. Calabrese P., Tavare S., Shibata D. Pretumor progression: clonal evolution of human stem cell populations. American Journal of Pathology. 2004;164:1337–1346. [PMC free article: PMC1615336] [PubMed: 15039221]
  58. Carey, J. R. 2003. Longevity: The Biology of Life Span. Princeton University Press, Princeton, NJ.
  59. Charles D. R., Luce-Clausen E. M. The kinetics of papilloma formation in benzpyrene-treated mice. Cancer Research. 1942;2:261–263.
  60. Charlesworth B., Partridge L. Ageing: levelling of the grim reaper. Current Biology. 1997;7:R440–442. [PubMed: 9210361]
  61. Chen P. C., Dudley S., Hagen W., Dizon D., Paxton L., Reichow D., Yoon S. R., Yang K., Arnheim N., Liskay R. M., Lipkin S. M. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse. Cancer Research. 2005;65:8662–8670. [PubMed: 16204034]
  62. Cheng T. C., Chen S. T., Huang C. S., Fu Y. P., Yu J. C., Cheng C. W., Wu P. E., Shen C. Y. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. International Journal of Cancer. 2005;113:345–353. [PubMed: 15455371]
  63. Cheshier S. H., Morrison S. J., Liao X., Weissman I. L. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:3120–3125. [PMC free article: PMC15905] [PubMed: 10077647]
  64. Chuong C. M., Dhouailly D., Gilmore S., Forest L., Shelley W. B., Stenn K. S., Maini P., Michon F., Parimoo S., Cadau S., Demongeot J., Zheng Y., Paus R., Happle R. What is the biological basis of pattern formation of skin lesions? Experimental Dermatology. 2006;15:547–549. [PMC free article: PMC4386655] [PubMed: 16761964]
  65. Clara, M., Herschel, K., and Ferner, H. 1974. Atlas of Normal Microscopic Anatomy of Man. Urban and Schwarzenberg, New York.
  66. Clarke R. B., Anderson E., Howell A., Potten C. S. Regulation of human breast epithelial stem cells. Cell Proliferation. 2003;36(Suppl 1):45–58. [PubMed: 14521515]
  67. Clemmesen, J. 1964. Statistical Studies in the Aetiology of Malignant Neoplasms, Vol. 174 of Acta Pathologica et Microbiologica Scandinavica. Supplement. Munksgaard, Copenhagen. [PubMed: 14313416]
  68. Clemmesen, J. 1969. Statistical Studies in the Aetiology of Malignant Neoplasms, Vol. 209 of Acta Pathologica et Microbiologica Scandinavica. Supplement. Munksgaard, Copenhagen. [PubMed: 5267218]
  69. Clemmesen, J. 1974. Statistical Studies in the Aetiology of Malignant Neoplasms, Vol. 247 of Acta Pathologica et Microbiologica Scandinavica. Supplement. Munksgaard, Copenhagen. [PubMed: 4458385]
  70. Cloos J., Nieuwenhuis E. J., Boomsma D. I., Kuik D. J., van der Sterre M. L., Arwert F., Snow G. B., Braakhuis B. J. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. Journal of the National Cancer Institute. 1999;91:1125–1130. [PubMed: 10393720]
  71. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358:1389–1399. [PubMed: 11705483]
  72. Cook P. J., Doll R., Fellingham S. A. A mathematical model for the age distribution of cancer in man. International Journal of Cancer. 1969;4:93–112. [PubMed: 5346480]
  73. Cotsarelis G., Sun T. T., Lavker R. M. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990;61:1329–1337. [PubMed: 2364430]
  74. Couch F. J., Weber B. L. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Human Mutation. 1996;8:8–18. [PubMed: 8807330]
  75. Couch, F. J., and Weber, B. L. 2002. Breast cancer. In Vogelstein, B., and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd edition)., pp. 549–581. McGraw-Hill, New York.
  76. Crowe, F. W., Schull, W. J., and Neel, J. V. 1956. A Clinical, Pathological and Genetic Study of Multiple Neurofibromatosis. Charles C Thomas, Springfield, IL.
  77. Cunningham M. L., Matthews H. B. Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens. Toxicology Letters. 1995;82–83:9–14. [PubMed: 8597159]
  78. Czene K., Lichtenstein P., Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. International Journal of Cancer. 2002;99:260–266. [PubMed: 11979442]
  79. Dahmen R. P., Koch A., Denkhaus D., Tonn J. C., Sorensen N., Berthold F., Behrens J., Birchmeier W., Wiestler O. D., Pietsch T. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Research. 2001;61:7039–7043. [PubMed: 11585731]
  80. Day N. E., Brown C. C. Multistage models and primary prevention of cancer. Journal of the National Cancer Institute. 1980;64:977–989. [PubMed: 6929006]
  81. de Boer J. G. Polymorphisms in DNA repair and environmental interactions. Mutation Research. 2002;509:201–210. [PubMed: 12427539]
  82. de la Chapelle A. Genetic predisposition to colorectal cancer. Nature Reviews Cancer. 2004;4:769–780. [PubMed: 15510158]
  83. de Rooij D. G. Stem cells in the testis. International Journal of Experimental Pathology. 1998;79:67–80. [PMC free article: PMC3230838] [PubMed: 9709376]
  84. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nature Reviews Cancer. 2005;5:275–284. [PubMed: 15803154]
  85. Deelman H. T. The part played by injury and repair in the development of cancer, with remarks on the growth of experimental cancer. British Medical Journal. 1927;1:872–874. [PMC free article: PMC2454682] [PubMed: 20773186]
  86. DeMars, R. 1970. Discussion comments following a paper by D. E. Anderson. In Genetic Concepts and Neoplasia: Proceedings of the 23rd Symposium on Fundamental Cancer Research, pp. 105–106. Williams & Wilkins, Baltimore.
  87. Doll R. The age distribution of cancer: implications for models of carcinogenesis. Journal of the Royal Statistical Society, Series A. 1971;134:133–166.
  88. Doll R. Uncovering the effects of smoking: historical perspective. Statistical Methods in Medical Research. 1998;7:87–117. [PubMed: 9654637]
  89. Doll R., Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. Journal of Epidemiology and Community Health. 1978;32:303–313. [PMC free article: PMC1060963] [PubMed: 744822]
  90. Dontu G., Al-Hajj M., Abdallah W. M., Clarke M. F., Wicha M. S. Stem cells in normal breast development and breast cancer. Cell Proliferation. 2003;36(Suppl 1):59–72. [PubMed: 14521516]
  91. Douma S., Van Laar T., Zevenhoven J., Meuwissen R., Van Garderen E., Peeper D. S. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature. 2004;430:1034–1039. [PubMed: 15329723]
  92. Drake J. W., Charlesworth B., Charlesworth D., Crow J. F. Rates of spontaneous mutation. Genetics. 1998;148:1667–1686. [PMC free article: PMC1460098] [PubMed: 9560386]
  93. Druckrey, H. 1967. Quantitative aspects in chemical carcinogenesis. In Truhaut, R., ed., Potential Carcinogenic Hazards from Drugs, pp. 60–78. Springer-Verlag, Berlin.
  94. Dyson F. A meeting with Enrico Fermi. Nature. 2004;427:297. [PubMed: 14737148]
  95. Edelmann L., Edelmann W. Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2004;129:91–99. [PubMed: 15264277]
  96. Egger G., Liang G., Aparicio A., Jones P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–463. [PubMed: 15164071]
  97. Evans, H. J. 1984. Genetic damage and cancer. In Bishop, J. M., Rowley, J. D., and Greaves, M., eds., Genes and Cancer, pp. 3–18. Alan R. Liss, New York.
  98. Fearnhead N. S., Wilding J. L., Winney B., Tonks S., Bartlett S., Bicknell D. C., Tomlinson I. P., Mortensen N. J., Bodmer W. F. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:15992–15997. [PMC free article: PMC528777] [PubMed: 15520370]
  99. Fearon, E. R. 2002. Tumor-suppressor genes. In Vogelstein, B., and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd edition)., pp. 197–206. McGraw-Hill, New York.
  100. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767. [PubMed: 2188735]
  101. Feinberg A. P., Tycko B. The history of cancer epigenetics. Nature Reviews Cancer. 2004;4:143–153. [PubMed: 14732866]
  102. Feldser D. M., Hackett J. A., Greider C. W. Telomere dysfunction and the initiation of genome instability. Nature Reviews Cancer. 2003;3:623–627. [PubMed: 12894250]
  103. Felsenstein, J. 2003. Inferring Phylogenies. Sinauer Associates, Sunderland, MA.
  104. Fidler I. J. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nature Reviews Cancer. 2003;3:453–458. [PubMed: 12778135]
  105. Fishel R. The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis. Cancer Research. 2001;61:7369–7374. [PubMed: 11606363]
  106. Fisher J. C. Multiple-mutation theory of carcinogenesis. Nature. 1958;181:651–652. [PubMed: 13517260]
  107. Fisher J. C., Hollomon J. H. A hypothesis for the origin of cancer foci. Cancer. 1951;4:916–918. [PubMed: 14879355]
  108. Folkman J. Role of angiogenesis in tumor growth and metastasis. Seminars in Oncology. 2002;29:15–18. [PubMed: 12516034]
  109. Folkman J. Fundamental concepts of the angiogenic process. Current Molecular Medicine. 2003;3:643–651. [PubMed: 14601638]
  110. Forbes W. F., Gibberd R. W. Mathematical models of carcinogenesis: a review. Mathematical Scientist. 1984;9:95–110.
  111. Ford D., Easton D. F., Stratton M. R., Narod S., Goldgar D., Devilee P., Bishop D. T., Weber B. L., Lenoir G., Chang-Claude J., Sobol H., Teare M. D., Struewing J. P., Arason A., Scherneck S., Peto J., Rebbeck T. R., Tonin P., Neuhausen S., Barkardottir R., Eyfjord J., Lynch H. T., Ponder B. A. et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. American Journal of Human Genetics. 1998;62:676–689. [PMC free article: PMC1376944] [PubMed: 9497246]
  112. Foulds, L. 1969. Neoplastic Development, Vol. 1. Academic Press, New York.
  113. Fraga M. F., Ballestar E., Paz M. F., Ropero S., Setien F., Ballestar M. L., Heine-Suner D., Cigudosa J. C., Urioste M., Benitez J., Boix-Chornet M., Sanchez-Aguilera A., Ling C., Carlsson E., Poulsen P., Vaag A., Stephan Z., Spector T. D., Wu Y.-Z., Plass C., Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:10604–10609. [PMC free article: PMC1174919] [PubMed: 16009939]
  114. Frame S., Crombie R., Liddell J., Stuart D., Linardopoulos S., Nagase H., Portella G., Brown K., Street A., Akhurst R., Balmain A. Epithelial carcinogenesis in the mouse: correlating the genetics and the biology. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 1998;353:839–845. [PMC free article: PMC1692278] [PubMed: 9684281]
  115. Frank S. A. Mutual policing and repression of competition in the evolution of cooperative groups. Nature. 1995;377:520–522. [PubMed: 7566147]
  116. Frank S. A. Perspective: repression of competition and the evolution of cooperation. Evolution. 2003a;57:693–705. [PubMed: 12778541]
  117. Frank S. A. Somatic mosaicism and cancer: inference based on a conditional Luria-Delbruck distribution. Journal of Theoretical Biology. 2003b;223:405–412. [PubMed: 12875820]
  118. Frank S. A. Somatic mutation: early cancer steps depend on tissue architecture. Current Biology. 2003c;13:R261–263. [PubMed: 12676101]
  119. Frank S. A. A multistage theory of age-specific acceleration in human mortality. BMC Biology. 2004a;2:16. [PMC free article: PMC471577] [PubMed: 15242520]
  120. Frank S. A. Age-specific acceleration of cancer. Current Biology. 2004b;14:242–246. [PubMed: 14761658]
  121. Frank S. A. Commentary: Mathematical models of cancer progression and epidemiology in the age of high throughput genomics. International Journal of Epidemiology. 2004c;33:1179–1181. [PubMed: 15319407]
  122. Frank S. A. Genetic predisposition to cancer—insights from population genetics. Nature Reviews Genetics. 2004d;5:764–772. [PubMed: 15510167]
  123. Frank S. A. Genetic variation in cancer predisposition: mutational decay of a robust genetic control network. Proceedings of the National Academy of Sciences of the United States of America. 2004e;101:8061–8065. [PMC free article: PMC419557] [PubMed: 15141087]
  124. Frank S. A. Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:1071–1075. [PMC free article: PMC545832] [PubMed: 15657129]
  125. Frank S. A., Chen P. C., Lipkin S. M. Kinetics of cancer: a method to test hypotheses of genetic causation. BMC Cancer. 2005;5:163. [PMC free article: PMC1352380] [PubMed: 16371164]
  126. Frank S. A., Iwasa Y., Nowak M. A. Patterns of cell division and the risk of cancer. Genetics. 2003;163:1527–1532. [PMC free article: PMC1462514] [PubMed: 12702695]
  127. Frank S. A., Nowak M. A. Developmental predisposition to cancer. Nature. 2003;422:494. [PubMed: 12673242]
  128. Frank S. A., Nowak M. A. Problems of somatic mutation and cancer. Bioessays. 2004;26:291–299. [PubMed: 14988930]
  129. Frayling I. M., Beck N. E., Ilyas M., Dove-Edwin I., Goodman P., Pack K., Bell J. A., Williams C. B., Hodgson S. V., Thomas H. J., Talbot I. C., Bodmer W. F., Tomlinson I. P. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:10722–10727. [PMC free article: PMC27962] [PubMed: 9724771]
  130. Freedman D. A., Navidi W. C. Multistage models for carcinogenesis. Environmental Health Perspectives. 1989;81:169–188. [PMC free article: PMC1567550] [PubMed: 2667978]
  131. Friedewald W. F., Rous P. The initiating and promoting elements in tumor production: an analysis of the effects of tar, benzopyrene and methyl-cholanthrene on rabbit skin. Journal of Experimental Medicine. 1944;80:101–125. [PMC free article: PMC2135455] [PubMed: 19871401]
  132. Frumkin D., Wasserstrom A., Kaplan S., Feige U., Shapiro E. Genomic variability within an organism exposes its cell lineage tree. PLoS Computational Biology. 2005;1:e50. [PMC free article: PMC1274291] [PubMed: 16261192]
  133. Gaffney M., Altshuler B. Examination of the role of cigarette smoke in lung carcinogenesis using multistage models. Journal of the National Cancer Institute. 1988;80:925–931. [PubMed: 3398067]
  134. Garcia-Closas M., Malats N., Real F. X., Welch R., Kogevinas M., Chatterjee N., Pfeiffer R., Silverman D., Dosemeci M., Tardon A., Serra C., Carrato A., Garcia-Closas R., Castano-Vinyals G., Chanock S., Yeager M., Rothman N. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiology, Biomarkers and Prevention. 2006;15:536–542. [PubMed: 16537713]
  135. Gavrilov L. A., Gavrilova N. S. The reliability theory of aging and longevity. Journal of Theoretical Biology. 2001;213:527–545. [PubMed: 11742523]
  136. Genereux D. P., Miner B. E., Bergstrom C. T., Laird C. D. A population-epigenetic model to infer site-specific methylation rates from double-stranded DNA methylation patterns. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:5802–5807. [PMC free article: PMC556300] [PubMed: 15827124]
  137. Ghazizadeh S., Taichman L. B. Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO Journal. 2001;20:1215–1222. [PMC free article: PMC145528] [PubMed: 11250888]
  138. Ghazizadeh S., Taichman L. B. Organization of stem cells and their progeny in human epidermis. Journal of Investigative Dermatology. 2005;124:367–372. [PMC free article: PMC3171174] [PubMed: 15675956]
  139. Giebel B., Zhang T., Beckmann J., Spanholtz J., Wernet P., Ho A. D., Punzel M. Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division. Blood. 2006;107:2146–2152. [PubMed: 16249381]
  140. Gottlieb B., Beitel L. K., Trifiro M. A. Somatic mosaicism and variable expressivity. Trends in Genetics. 2001;17:79–82. [PubMed: 11173116]
  141. Greenhalgh D. A., Wang X. J., Donehower L. A., Roop D. R. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Cancer Research. 1996;56:4413–4423. [PubMed: 8813135]
  142. Greenlee R. T., Murray T., Bolden S., Wingo P. A. Cancer statistics, 2000. CA: A Cancer Journal for Clinicians. 2000;50:7–33. [PubMed: 10735013]
  143. Grossman, L., Matanoski, G., Farmer, E., Hedayati, M., Ray, S., Trock, B., Hanfelt, J., Roush, G., Berwick, M., and Hu, J. J. 1999. DNA repair as a susceptibility factor in chronic diseases in human populations. In Dizdaroglu, M., and Karakaya, A. E., eds., Advances in DNA Damage and Repair, pp. 149–167. Kluwer Academic/Plenum Publishers, New York.
  144. Gu J., Zhao H., Dinney C. P., Zhu Y., Leibovici D., Bermejo C. E., Grossman H. B., Wu X. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clinical Cancer Research. 2005;11:1408–1415. [PubMed: 15746040]
  145. Guerrette S., Acharya S., Fishel R. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. Journal of Biological Chemistry. 1999;274:6336–6341. [PubMed: 10037723]
  146. Guerrette S., Wilson T., Gradia S., Fishel R. Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer. Molecular and Cellular Biology. 1998;18:6616–6623. [PMC free article: PMC109246] [PubMed: 9774676]
  147. Gutmann, D. H., and Collins, F. S. 2002. Neurofibromatosis I. In Vogelstein, B., and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd edition)., pp. 417–437. McGraw-Hill, New York.
  148. Haenszel W., Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. Journal of the National Cancer Institute. 1968;40:43–68. [PubMed: 5635018]
  149. Hall, B. G. 2004. Phylogenetic Trees Made Easy: A How-To Manual (2nd edition). Sinauer Associates, Sunderland, MA.
  150. Halpern M. T., Gillespie B. W., Warner K. E. Patterns of absolute risk of lung cancer mortality in former smokers. Journal of the National Cancer Institute. 1993;85:457–464. [PubMed: 8445673]
  151. Han J., Colditz G. A., Samson L. D., Hunter D. J. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Research. 2004;64:3009–3013. [PubMed: 15126335]
  152. Hanahan D., Weinberg R. A. The hallmarks of cancer. Cell. 2000;100:57–70. [PubMed: 10647931]
  153. Happle R. Mosaicism in human skin. Understanding the patterns and mechanisms. Archives of Dermatology. 1993;129:1460–1470. [PubMed: 8239703]
  154. Happle R. Loss of heterozygosity in human skin. Journal of the American Academy of Dermatology. 1999;41:143–164. [PubMed: 10426882]
  155. Happle R., Konig A. Type 2 segmental manifestation of multiple glomus tumors: a review and reclassification of 5 case reports. Dermatology. 1999;198:270–272. [PubMed: 10393451]
  156. Harpending H., Cochran G. Genetic diversity and genetic burden in humans. Infection, Genetics and Evolution. 2006;6:154–162. [PubMed: 16246638]
  157. Hartman M., Czene K., Reilly M., Bergh J., Lagiou P., Trichopoulos D., Adami H. O., Hall P. Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncology. 2005;6:377–382. [PubMed: 15925815]
  158. Hendry J. H., Potten C. S., Chadwick C., Bianchi M. Cell death (apoptosis) in the mouse small intestine after low doses: effects of dose-rate, 14.7 MeV neutrons, and 600 MeV (maximum energy) neutrons. International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine. 1982;42:611–620. [PubMed: 6984434]
  159. Hethcote H. W., Knudson A. G. Model for the incidence of embryonal cancers: application to retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1978;75:2453–2457. [PMC free article: PMC392572] [PubMed: 276883]
  160. Horiuchi S., Wilmoth J. R. Age patterns of the life table aging rate for major causes of death in Japan, 1951–1990. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 1997;52:B67–77. [PubMed: 9008660]
  161. Horiuchi S., Wilmoth J. R. Deceleration in the age pattern of mortality at older ages. Demography. 1998;35:391–412. [PubMed: 9850465]
  162. Hotary K. B., Allen E. D., Brooks P. C., Datta N. S., Long M. W., Weiss S. J. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell. 2003;114:33–45. [PubMed: 12859896]
  163. Houle D. Comparing evolvability and variability of quantitative traits. Genetics. 1992;130:195–204. [PMC free article: PMC1204793] [PubMed: 1732160]
  164. Hsieh P. Molecular mechanisms of DNA mismatch repair. Mutation Research. 2001;486:71–87. [PubMed: 11425513]
  165. Hu M., Yao J., Cai L., Bachman K. E., van den Brule F., Velculescu V., Polyak K. Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genetics. 2005;37:899–905. [PubMed: 16007089]
  166. Hunter, J. A. A., Savin, J., and Dahl, M. V. 1995. Clinical Dermatology (2nd edition). Blackwell Science, Oxford.
  167. Hunter K. D., Parkinson E. K., Harrison P. R. Profiling early head and neck cancer. Nature Reviews Cancer. 2005;5:127–135. [PubMed: 15685196]
  168. Huntly B. J., Gilliland D. G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nature Reviews Cancer. 2005;5:311–321. [PubMed: 15803157]
  169. Huson S. M., Compston D. A., Clark P., Harper P. S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. Journal of Medical Genetics. 1989;26:704–711. [PMC free article: PMC1015740] [PubMed: 2511318]
  170. Issa J. P. CpG-island methylation in aging and cancer. Current Topics in Microbiology and Immunology. 2000;249:101–118. [PubMed: 10802941]
  171. Issa J. P. Opinion: CpG island methylator phenotype in cancer. Nature Reviews Cancer. 2004;4:988–993. [PubMed: 15573120]
  172. Iversen O. H. Of mice and men: a critical reappraisal of the two-stage theory of carcinogenesis. Critical Reviews in Oncogenesis. 1995;6:357–405. [PubMed: 9012591]
  173. Janes S. M., Lowell S., Hutter C. Epidermal stem cells. Journal of Pathology. 2002;197:479–491. [PubMed: 12115864]
  174. Jass J. R. Serrated adenoma of the colorectum: a lesion with teeth. American Journal of Pathology. 2003;162:705–708. [PMC free article: PMC1868111] [PubMed: 12598303]
  175. Jass J. R., Whitehall V. L., Young J., Leggett B. A. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002a;123:862–876. [PubMed: 12198712]
  176. Jass J. R., Young J., Leggett B. A. Evolution of colorectal cancer: change of pace and change of direction. Journal of Gastroenterology and Hepatology. 2002b;17:17–26. [PubMed: 11987262]
  177. Jiang W., Ananthaswamy H. N., Muller H. K., Kripke M. L. p53 protects against skin cancer induction by UV-B radiation. Oncogene. 1999;18:4247–4253. [PubMed: 10435637]
  178. Jonason A. S., Kunala S., Price G. J., Restifo R. J., Spinelli H. M., Persing J. A., Leffell D. J., Tarone R. E., Brash D. E. Frequent clones of p53-mutated keratinocytes in normal human skin. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:14025–14029. [PMC free article: PMC19488] [PubMed: 8943054]
  179. Jones P. A., Baylin S. B. The fundamental role of epigenetic events in cancer. Nature Reviews Genetics. 2002;3:415–428. [PubMed: 12042769]
  180. Karpowicz P., Morshead C., Kam A., Jervis E., Ramunas J., Cheng V., van der Kooy D. Support for the immortal strand hypothesis: neural stem cells partition DNA asymmetrically in vitro. Journal of Cell Biology. 2005;170:721–732. [PMC free article: PMC2171352] [PubMed: 16115957]
  181. Kastan M. B., Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316–323. [PubMed: 15549093]
  182. Kemp C. J., Donehower L. A., Bradley A., Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 1993;74:813–822. [PubMed: 8374952]
  183. Kim B. G., Li C., Qiao W., Mamura M., Kasperczak B., Anver M., Wolfraim L., Hong S., Mushinski E., Potter M., Kim S. J., Fu X. Y., Deng C., Letterio J. J. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature. 2006;441:1015–1019. [PubMed: 16791201]
  184. Kim J. Y., Tavare S., Shibata D. Counting human somatic cell replications: methylation mirrors endometrial stem cell divisions. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:17739–17744. [PMC free article: PMC1308885] [PubMed: 16314580]
  185. Kim J. Y., Tavare S., Shibata D. Human hair genealogies and stem cell latency. BMC Biology. 2006;4:2. [PMC free article: PMC1386708] [PubMed: 16457718]
  186. Kim K. M., Calabrese P., Tavare S., Shibata D. Enhanced stem cell survival in familial adenomatous polyposis. American Journal of Pathology. 2004;164:1369–1377. [PMC free article: PMC1615334] [PubMed: 15039224]
  187. Kim K. M., Shibata D. Methylation reveals a niche: stem cell succession in human colon crypts. Oncogene. 2002;21:5441–5449. [PubMed: 12154406]
  188. Kim K. M., Shibata D. Tracing ancestry with methylation patterns: most crypts appear distantly related in normal adult human colon. BMC Gastroenterology. 2004;4:8. [PMC free article: PMC400737] [PubMed: 15059289]
  189. Kinzler K. W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170. [PubMed: 8861899]
  190. Kinzler K. W., Vogelstein B. Landscaping the cancer terrain. Science. 1998;280:1036–1037. [PubMed: 9616081]
  191. Kinzler, K. W., and Vogelstein, B. 2002. Colorectal tumors. In Vogelstein, B., and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd edition)., pp. 583–612. McGraw-Hill, New York.
  192. Kirkwood T. B. Understanding the odd science of aging. Cell. 2005;120:437–447. [PubMed: 15734677]
  193. Klein G. Foulds' dangerous idea revisited: the multistep development of tumors 40 years later. Advances in Cancer Research. 1998;72:1–23. [PubMed: 9338072]
  194. Knudson A. G. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1971;68:820–823. [PMC free article: PMC389051] [PubMed: 5279523]
  195. Knudson, A. G. 1977. Genetic predisposition to cancer. In Hiatt, H. H., Watson, J. D., and Winsten, J. A., eds., Origins of Human Cancer, pp. 45–52. Cold Spring Harbor Publications, New York.
  196. Knudson A. G. Antioncogenes and human cancer. Proceedings of the National Academy of Sciences of the United States of America. 1993;90:10914–10921. [PMC free article: PMC47892] [PubMed: 7902574]
  197. Knudson A. G. Two genetic hits (more or less) to cancer. Nature Reviews Cancer. 2001;1:157–162. [PubMed: 11905807]
  198. Knudson A. G. Cancer genetics through a personal retrospectroscope. Genes, Chromosomes and Cancer. 2003;38:288–291. [PubMed: 14566844]
  199. Knudson A. G., Hethcote H. W., Brown B. W. Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1975;72:5116–5120. [PMC free article: PMC388887] [PubMed: 1061095]
  200. Kohler S. W., Provost G. S., Fieck A., Kretz P. L., Bullock W. O., Sorge J. A., Putman D. L., Short J. M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 1991;88:7958–7962. [PMC free article: PMC52424] [PubMed: 1832771]
  201. Komarova N. L., Sengupta A., Nowak M. A. Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. Journal of Theoretical Biology. 2003;223:433–450. [PubMed: 12875822]
  202. Kondo M., Wagers A. J., Manz M. G., Prohaska S. S., Scherer D. C., Beilhack G. F., Shizuru J. A., Weissman I. L. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annual Review of Immunology. 2003;21:759–806. [PubMed: 12615892]
  203. Kroemer G. Cell death and cancer: an introduction. Oncogene. 2004;23:2744–2745.
  204. Kuo M. H., Allis C. D. Roles of histone acetyltransferases and deacety-lases in gene regulation. Bioessays. 1998;20:615–626. [PubMed: 9780836]
  205. Kwabi-Addo B., Giri D., Schmidt K., Podsypanina K., Parsons R., Greenberg N., Ittmann M. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:11563–11568. [PMC free article: PMC58769] [PubMed: 11553783]
  206. Lajtha L. G. Stem cell concepts. Differentiation. 1979;14:23–34. [PubMed: 383561]
  207. Lamlum H., Al Tassan N., Jaeger E., Frayling I. M., Sieber O., Reza F. B., Eckert M., Rowan A., Barclay E., Atkin W., Williams C. B., Gilbert J., Cheadle J., Bell J. A., Houlston R., Bodmer W. F., Sampson J., Tomlinson I. P. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Human Molecular Genetics. 2000;9:2215–2221. [PubMed: 11001924]
  208. Lang D., Lu M. M., Huang L., Engleka K. A., Zhang M., Chu E. Y., Lipner S., Skoultchi A., Millar S. E., Epstein J. A. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature. 2005;433:884–887. [PubMed: 15729346]
  209. Lawley P. D. Historical origins of current concepts of carcinogenesis. Advances in Cancer Research. 1994;65:17–111. [PubMed: 7879666]
  210. Lechler T., Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature. 2005;437:275–280. [PMC free article: PMC1399371] [PubMed: 16094321]
  211. Lee C. Irresistible force meets immovable object: SNP mapping of complex diseases. Trends in Genetics. 2002;18:67–69. [PubMed: 11818133]
  212. Lichten M., Haber J. E. Position effects in ectopic and allelic mitotic recombination in Saccharomyces cerevisiae. Genetics. 1989;123:261–268. [PMC free article: PMC1203798] [PubMed: 2684745]
  213. Lichtenstein P., Holm N. V., Verkasalo P. K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. New England Journal of Medicine. 2000;343:78–85. [PubMed: 10891514]
  214. Limpert E., Stahel W. A., Abbt M. Log-normal distributions across the sciences: keys and clues. Bioscience. 2001;51:341–352.
  215. Liotta L. A., Kohn E. C. The microenvironment of the tumour-host interface. Nature. 2001;411:375. [PubMed: 11357145]
  216. Lipkin S. M., Wang V., Jacoby R., Banerjee-Basu S., Baxevanis A. D., Lynch H. T., Elliott R. M., Collins F. S. MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nature Genetics. 2000;24:27–35. [PubMed: 10615123]
  217. Liu S., Dontu G., Wicha M. S. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Research. 2005;7:86–95. [PMC free article: PMC1143566] [PubMed: 15987436]
  218. Loeb L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Research. 1991;51:3075–3079. [PubMed: 2039987]
  219. Loeb L. A. Cancer cells exhibit a mutator phenotype. Advances in Cancer Research. 1998;72:25–56. [PubMed: 9338073]
  220. Loeb L. A., Springgate C. F., Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Research. 1974;34:2311–2321. [PubMed: 4136142]
  221. Lowe S. W., Cepero E., Evan G. Intrinsic tumour suppression. Nature. 2004;432:307–315. [PubMed: 15549092]
  222. Luebeck E. G., Moolgavkar S. H. Multistage carcinogenesis and the incidence of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:15095–15100. [PMC free article: PMC137549] [PubMed: 12415112]
  223. Luria S. E., Delbrück M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics. 1943;28:491–511. [PMC free article: PMC1209226] [PubMed: 17247100]
  224. Lutz W. K. Dose-response relationships in chemical carcinogenesis reflect differences in individual susceptibility. Consequences for cancer risk assessment, extrapolation, and prevention. Human and Experimental Toxicology. 1999;18:707–712. [PubMed: 10627656]
  225. Lynch H. T., Smyrk T., Jass J. R. Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? Seminars in Surgical Oncology. 1995;11:406–410. [PubMed: 8607009]
  226. Lynch, M., and Walsh, B. 1998. Genetics and Analysis of Quantitative Traits. Sinauer, Sunderland, MA.
  227. MacKenzie I., Rous P. The experimental disclosure of latent neoplastic transformation in tarred skin. Journal of Experimental Medicine. 1940;71:391–416. [PMC free article: PMC2135138] [PubMed: 19871085]
  228. Maley C. C., Galipeau P. C., Finley J. C., Wongsurawat V. J., Li X., Sanchez C. A., Paulson T. G., Blount P. L., Risques R. A., Rabinovitch P. S., Reid B. J. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genetics. 2006;38:468–473. [PubMed: 16565718]
  229. Mao J. H., Lindsay K. A., Balmain A., Wheldon T. E. Stochastic modelling of tumorigenesis in p53 deficient mice. British Journal of Cancer. 1998;77:243–252. [PMC free article: PMC2151221] [PubMed: 9460995]
  230. Marsh D., Zori R. Genetic insights into familial cancers—update and recent discoveries. Cancer Letters. 2002;181:125–164. [PubMed: 12175530]
  231. Marshman E., Booth C., Potten C. S. The intestinal epithelial stem cell. Bioessays. 2002;24:91–98. [PubMed: 11782954]
  232. Mathon N. F., Lloyd A. C. Cell senescence and cancer. Nature Reviews Cancer. 2001;1:203–213. [PubMed: 11902575]
  233. Maynard Smith, J., and Szathmary, E. 1995. The Major Transitions in Evolution. W. H. Freeman, New York.
  234. Merok J. R., Lansita J. A., Tunstead J. R., Sherley J. L. Cosegregation of chromosomes containing immortal DNA strands in cells that cycle with asymmetric stem cell kinetics. Cancer Research. 2002;62:6791–6795. [PubMed: 12460886]
  235. Meza R., Luebeck E. G., Moolgavkar S. H. Gestational mutations and carcinogenesis. Mathematical Biosciences. 2005;197:188–210. [PubMed: 16087198]
  236. Michor F., Iwasa Y., Komarova N. L., Nowak M. A. Local regulation of homeostasis favors chromosomal instability. Current Biology. 2003;13:581–584. [PubMed: 12676089]
  237. Michor F., Iwasa Y., Nowak M. A. Dynamics of cancer progression. Nature Reviews Cancer. 2004;4:197–205. [PubMed: 14993901]
  238. Mitchell R. J., Farrington S. M., Dunlop M. G., Campbell H. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. American Journal of Epidemiology. 2002;156:885–902. [PubMed: 12419761]
  239. Mohrenweiser H. W., Wilson D. M., Jones I. M. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutation Research. 2003;526:93–125. [PubMed: 12714187]
  240. Moolgavkar S. H. The multistage theory of carcinogenesis and the age distribution of cancer in man. Journal of the National Cancer Institute. 1978;61:49–52. [PubMed: 276637]
  241. Moolgavkar S. H. Commentary: Fifty years of the multistage model: remarks on a landmark paper. International Journal of Epidemiology. 2004;33:1182–1183. [PubMed: 15319398]
  242. Moolgavkar S. H., Dewanji A., Luebeck E. G. Cigarette smoking and lung cancer: reanalysis of the British doctors' data. Journal of the National Cancer Institute. 1989;81:415–420. [PubMed: 2783979]
  243. Moolgavkar S. H., Knudson A. G. Mutation and cancer: a model for human carcinogenesis. Journal of the National Cancer Institute. 1981;66:1037–1052. [PubMed: 6941039]
  244. Moolgavkar, S. H., Krewski, D., and Schwarz, M. 1999. Mechanisms of carcinogenesis and biologically-based models for quantitative estimation and prediction of cancer risk. In Moolgavkar, S. H., Krewski, D., Zeise, L., Cardis, E., and Moller, H., eds., Quantitative Estimation and Prediction of Cancer Risk, pp. 179–238. IARC Scientific Publications, Lyon.
  245. Moolgavkar S. H., Venzon D. J. Two-event models for carcinogenesis: incidence curves for childhood and adult tumors. Mathematical Biosciences. 1979;47:55–77.
  246. Morris R. J. A perspective on keratinocyte stem cells as targets for skin carcinogenesis. Differentiation. 2004;72:381–386. [PubMed: 15606497]
  247. Morris R. J., Liu Y., Marles L., Yang Z., Trempus C., Li S., Lin J. S., Sawicki J. A., Cotsarelis G. Capturing and profiling adult hair follicle stem cells. Nature Biotechnology. 2004;22:411–417. [PubMed: 15024388]
  248. Morrison S. J., Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006;441:1068–1074. [PubMed: 16810241]
  249. Mousseau T. A., Roff D. A. Natural selection and the heritability of fitness components. Heredity. 1987;59:181–197. [PubMed: 3316130]
  250. Mueller M. M., Fusenig N. E. Friends or foes—bipolar effects of the tumour stroma in cancer. Nature Reviews Cancer. 2004;4:839–849. [PubMed: 15516957]
  251. Muller, H. J. 1951. Radiation damage to the genetic material. In Baitsell, G. A., ed., Science in Progress: Seventh Series, pp. 93–165. Yale University Press, New Haven.
  252. Murray, J. D. 1989. Mathematical Biology. Springer-Verlag, New York.
  253. Newsham, I. F., Hadjistilianou, T., and Cavenee, W. K. 2002. Retinoblastoma. In Vogelstein, B., and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd edition)., pp. 357–386. McGraw-Hill, New York.
  254. Ng P. C., Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Research. 2003;31:3812–3814. [PMC free article: PMC168916] [PubMed: 12824425]
  255. Nishimura E. K., Jordan S. A., Oshima H., Yoshida H., Osawa M., Moriyama M., Jackson I. J., Barrandon Y., Miyachi Y., Nishikawa S. Dominant role of the niche in melanocyte stem-cell fate determination. Nature. 2002;416:854–860. [PubMed: 11976685]
  256. Nordling C. O. A new theory on cancer-inducing mechanism. British Journal of Cancer. 1953;7:68–72. [PMC free article: PMC2007872] [PubMed: 13051507]
  257. Nowak M. A., Komarova N. L., Sengupta A., Jallepalli P. V., Shih I., Vogelstein B., Lengauer C. The role of chromosomal instability in tumor initiation. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:16226–16231. [PMC free article: PMC138593] [PubMed: 12446840]
  258. Nowell P. C. The clonal evolution of tumor cell populations. Science. 1976;194:23–28. [PubMed: 959840]
  259. Nunney L. Lineage selection and the evolution of multistage carcinogenesis. Proceedings of the Royal Society of London. Series B: Biological Sciences. 1999;266:493–498. [PMC free article: PMC1689794] [PubMed: 10189713]
  260. Nunney L. The population genetics of multistage carcinogenesis. Proceedings of the Royal Society of London. Series B: Biological Sciences. 2003;270:1183–1191. [PMC free article: PMC1691357] [PubMed: 12816658]
  261. Page, R. D. M., and Holmes, E. C. 1998. Molecular Evolution: A Phylogenetic Approach. Blackwell Scientific, Oxford.
  262. Pardal R., Clarke M. F., Morrison S. J. Applying the principles of stem-cell biology to cancer. Nature Reviews Cancer. 2003;3:895–902. [PubMed: 14737120]
  263. Park, M. 2002. Oncogenes. In Vogelstein, B., and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd edition)., pp. 177–196. McGraw-Hill, New York.
  264. Park S. J., Rashid A., Lee J. H., Kim S. G., Hamilton S. R., Wu T. T. Frequent CpG island methylation in serrated adenomas of the colorectum. American Journal of Pathology. 2003;162:815–822. [PMC free article: PMC1868094] [PubMed: 12598316]
  265. Parkin, D. M., Whelan, S. L., Ferlay, J., Teppo, L., and Thomas, D. B., eds. 2002. Cancer Incidence in Five Continents, Vol. VIII. International Agency for Research on Cancer, Lyon, France.
  266. Pelengaris S., Khan M., Evan G. c-MYC: more than just a matter of life and death. Nature Reviews Cancer. 2002;2:764–776. [PubMed: 12360279]
  267. Peltomaki P., Vasen H. F. Mutations predisposing to hereditary non-polyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997;113:1146–1158. [PubMed: 9322509]
  268. Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411:390–395. [PubMed: 11357148]
  269. Peto J., Collins N., Barfoot R., Seal S., Warren W., Rahman N., Easton D. F., Evans C., Deacon J., Stratton M. R. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. Journal of the National Cancer Institute. 1999;91:943–949. [PubMed: 10359546]
  270. Peto J., Mack T. M. High constant incidence in twins and other relatives of women with breast cancer. Nature Genetics. 2000;26:411–414. [PubMed: 11101836]
  271. Peto, R. 1977. Epidemiology, multistage models and short-term mutagenicity tests. In Hiatt, H. H., Watson, J. D., and Winsten, J. A., eds., Origins of Human Cancer, pp. 1403–1428. Cold Spring Harbor Publications, New York.
  272. Peto R., Darby S., Deo H., Silcocks P., Whitley E., Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. British Medical Journal. 2000;321:323–329. [PMC free article: PMC27446] [PubMed: 10926586]
  273. Peto R., Gray R., Brantom P., Grasso P. Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Research. 1991;51:6452–6469. [PubMed: 1933907]
  274. Pfeifer G. P., Steigerwald S. D., Hansen R. S., Gartler S. M., Riggs A. D. Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:8252–8256. [PMC free article: PMC54933] [PubMed: 2236038]
  275. Pharoah P. D., Antoniou A., Bobrow M., Zimmern R. L., Easton D. F., Ponder B. A. Polygenic susceptibility to breast cancer and implications for prevention. Nature Genetics. 2002;31:33–36. [PubMed: 11984562]
  276. Pierce D. A., Vaeth M. Age-time patterns of cancer to be anticipated from exposure to general mutagens. Biostatistics. 2003;4:231–248. [PubMed: 12925519]
  277. Pike M. C., Krailo M. D., Henderson B. E., Casagrande J. T., Hoel D. G. Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature. 1983;303:767–770. [PubMed: 6866078]
  278. Pike M. C., Pearce C. L., Wu A. H. Prevention of cancers of the breast, endometrium and ovary. Oncogene. 2004;23:6379–6391. [PubMed: 15322512]
  279. Platt R. Clonal ageing and cancer. Lancet. 1955;265:867.
  280. Pletcher S. D., Curtsinger J. W. Mortality plateaus and the evolution of senescence: why are old-age mortality rates so low? Evolution. 1998;52:454–464.
  281. Popanda O., Schattenberg T., Phong C. T., Butkiewicz D., Risch A., Edler L., Kayser K., Dienemann H., Schulz V., Drings P., Bartsch H., Schmezer P. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25:2433–2441. [PubMed: 15333465]
  282. Potten C. S. The epidermal proliferative unit: the possible role of the central basal cell. Cell and Tissue Kinetics. 1974;7:77–88. [PubMed: 4129708]
  283. Potten C. S. Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature. 1977;269:518–521. [PubMed: 909602]
  284. Potten C. S. Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. International Review of Cytology. 1981;69:271–318. [PubMed: 6163744]
  285. Potten C. S. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 1998;353:821–830. [PMC free article: PMC1692280] [PubMed: 9684279]
  286. Potten C. S., Booth C. Keratinocyte stem cells: a commentary. Journal of Investigative Dermatology. 2002;119:888–899. [PubMed: 12406335]
  287. Potten C. S., Grant H. K. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. British Journal of Cancer. 1998;78:993–1003. [PMC free article: PMC2063142] [PubMed: 9792141]
  288. Potten C. S., Li Y. Q., O'Connor P. J., Winton D. J. A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis. 1992;13:2305–2312. [PubMed: 1473238]
  289. Potten C. S., Owen G., Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. Journal of Cell Science. 2002;115:2381–2388. [PubMed: 12006622]
  290. Prehn R. T. The role of mutation in the new cancer paradigm. Cancer Cell International. 2005;5:9. [PMC free article: PMC1090602] [PubMed: 15854226]
  291. Preston-Martin S., Pike M. C., Ross R. K., Jones P. A., Henderson B. E. Increased cell division as a cause of human cancer. Cancer Research. 1990;50:7415–7421. [PubMed: 2174724]
  292. R Development Core Team 2004. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna.
  293. Rajagopalan H., Bardelli A., Lengauer C., Kinzler K. W., Vogelstein B., Velculescu V. E. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418:934. [PubMed: 12198537]
  294. Rajagopalan H., Nowak M. A., Vogelstein B., Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nature Reviews Cancer. 2003;3:695–701. [PubMed: 12951588]
  295. Rambhatla L., Ram-Mohan S., Cheng J. J., Sherley J. L. Immortal DNA strand cosegregation requires p53/IMPDH-dependent asymmetric self-renewal associated with adult stem cells. Cancer Research. 2005;65:3155–3161. [PubMed: 15833845]
  296. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Research. 2002;30:3894–3900. [PMC free article: PMC137415] [PubMed: 12202775]
  297. Reya T., Morrison S. J., Clarke M. F., Weissman I. L. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. [PubMed: 11689955]
  298. Ries, L. A. G., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T., Young, J. L., and Bunin, G. R., eds. 1999. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, NIH Pub. No. 99–4649. National Cancer Institute, SEER Program, Bethesda, MD [http://seer​​/publications/childhood/].
  299. Rizzo S., Attard G., Hudson D. L. Prostate epithelial stem cells. Cell Proliferation. 2005;38:363–374. [PubMed: 16300650]
  300. Ro S., Rannala B. Methylation patterns and mathematical models reveal dynamics of stem cell turnover in the human colon. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:10519–10521. [PMC free article: PMC58493] [PubMed: 11553798]
  301. Roberts S. A., Spreadborough A. R., Bulman B., Barber J. B., Evans D. G., Scott D. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? American Journal of Human Genetics. 1999;65:784–794. [PMC free article: PMC1377987] [PubMed: 10441587]
  302. Robertson K. D. DNA methylation and human disease. Nature Reviews Genetics. 2005;6:597–610. [PubMed: 16136652]
  303. Rose, M. R. 1991. Evolutionary Biology of Aging. Oxford University Press, Oxford.
  304. Rose M. R., Mueller L. D. Ageing and immortality. Philosophical Transactions of the Royal Society of London, Series B. 2000;355:1657–1662. [PMC free article: PMC1692895] [PubMed: 11127912]
  305. Rous P., Kidd I. G. Conditional neoplasma and subthreshold neoplastic states: a study of tar tumors in rabbits. Journal of Experimental Medicine. 1941;73:365–389. [PMC free article: PMC2135131] [PubMed: 19871084]
  306. Rubin, H., ed. 2005. Microenvironmental Regulation of Tumor Development, Vol. 15 of Seminars in Cancer Biology. Saunders Scientific Publications, Philadelphia.
  307. Rudolph R. Familial multiple glomangiomas. Annals of Plastic Surgery. 1993;30:183–185. [PubMed: 8387739]
  308. Samuelsson B., Axelsson R. Neurofibromatosis. A clinical and genetic study of 96 cases in Gothenburg, Sweden. Acta Dermato-Venereologica. Supplementum. 1981;95:67–71. [PubMed: 6807042]
  309. Scherer, E., and Emmelot, P. 1979. Multihit kinetics of tumor cell formation and risk assessment of low doses of carcinogen. In Griffin, A. C., and Shaw, C. R., eds., Carcinogens: Identification and Mechanisms of Action, pp. 337–364. Raven Press, New York.
  310. Seligson D. B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., Kurdistani S. K. Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005;435:1262–1266. [PubMed: 15988529]
  311. Sell S. Stem cell origin of cancer and differentiation therapy. Critical Reviews in Oncology/Hematology. 2004;51:1–28. [PubMed: 15207251]
  312. Sergeyev A. S. On the mutation rate of neurofibromatosis. Humangenetik. 1975;28:129–138. [PubMed: 125227]
  313. Shibata D. Clonal diversity in tumor progression. Nature Genetics. 2006;38:402–403. [PubMed: 16570060]
  314. Shibata D., Tavare S. Counting divisions in a human somatic cell tree: how, what and why? Cell Cycle. 2006;5:610–614. [PubMed: 16582617]
  315. Shimodaira H., Filosi N., Shibata H., Suzuki T., Radice P., Kanamaru R., Friend S. H., Kolodner R. D., Ishioka C. Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nature Genetics. 1998;19:384–389. [PubMed: 9697702]
  316. Shizuru J. A., Negrin R. S., Weissman I. L. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annual Review of Medicine. 2005;56:509–538. [PubMed: 15660525]
  317. Shmookler Reis R. J., Goldstein S. Variability of DNA methylation patterns during serial passage of human diploid fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 1982;79:3949–3953. [PMC free article: PMC346553] [PubMed: 6287455]
  318. Sieber O., Heinimann K., Tomlinson I. P. Genomic stability and tumorigenesis. Seminars in Cancer Biology. 2005;15:61–66. [PubMed: 15613289]
  319. Siegel D. H., Sybert V. P. Mosaicism in genetic skin disorders. Pediatric Dermatology. 2006;23:87–92. [PubMed: 16445423]
  320. Simon R., Eltze E., Schafer K. L., Burger H., Semjonow A., Hertle L., Dockhorn-Dworniczak B., Terpe H. J., Bocker W. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Research. 2001;61:355–362. [PubMed: 11196186]
  321. Singh S. K., Clarke I. D., Hide T., Dirks P. B. Cancer stem cells in nervous system tumors. Oncogene. 2004;23:7267–7273. [PubMed: 15378086]
  322. Slaga T. J., Budunova I. V., Gimenez-Conti I. B., Aldaz C. M. The mouse skin carcinogenesis model. Journal of Investigative Dermatology. Symposium Proceedings. 1996;1:151–156. [PubMed: 9627710]
  323. Slaughter D. P., Southwick H. W., Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6:963–968. [PubMed: 13094644]
  324. Smalley K. S., Brafford P. A., Herlyn M. Selective evolutionary pressure from the tissue microenvironment drives tumor progression. Seminars in Cancer Biology. 2005;15:451–459. [PubMed: 16043361]
  325. Smith G. H. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development. 2005;132:681–687. [PubMed: 15647322]
  326. Sommer L. Checkpoints of melanocyte stem cell development. Science's STKE. 2005;2005:pe42. [PubMed: 16118396]
  327. Sontag L. B., Lorincz M. C., Luebeck E. G. Dynamics, stability and inheritance of somatic DNA methylation imprints. Journal of Theoretical Biology. 2006;242:890–899. [PubMed: 16806276]
  328. Stein W. D. Analysis of cancer incidence data on the basis of multistage and clonal growth models. Advances in Cancer Research. 1991;56:161–213. [PubMed: 2028841]
  329. Stellman S. D., Boffetta P., Garfinkel L. Smoking habits of 800,000 American men and women in relation to their occupations. American Journal of Industrial Medicine. 1988;13:43–58. [PubMed: 3257844]
  330. Stocks P. A study of the age curve for cancer of the stomach in connection with a theory of the cancer producing mechanism. British Journal of Cancer. 1953;7:407–417. [PMC free article: PMC2007915] [PubMed: 13126381]
  331. Storm S. M., Rapp U. R. Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors. Toxicology Letters. 1993;67:201–210. [PubMed: 8451761]
  332. Struewing J. P., Hartge P., Wacholder S., Baker S. M., Berlin M., McAdams M., Timmerman M. M., Brody L. C., Tucker M. A. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine. 1997;336:1401–1408. [PubMed: 9145676]
  333. Taibjee S. M., Bennett D. C., Moss C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. British Journal of Dermatology. 2004;151:269–282. [PubMed: 15327534]
  334. Takano H., Ema H., Sudo K., Nakauchi H. Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs. Journal of Experimental Medicine. 2004;199:295–302. [PMC free article: PMC2211802] [PubMed: 14744992]
  335. Tan, W. Y. 1991. Stochastic Models of Carcinogenesis. Marcel Dekker, New York.
  336. Taniguchi K., Roberts L. R., Aderca I. N., Dong X., Qian C., Murphy L. M., Nagorney D. M., Burgart L. J., Roche P. C., Smith D. I., Ross J. A., Liu W. Mutational spectrum of betacatenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002;21:4863–4871. [PubMed: 12101426]
  337. Tannergard P., Lipford J. R., Kolodner R., Frodin J. E., Nordenskjold M., Lindblom A. Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Research. 1995;55:6092–6096. [PubMed: 8521398]
  338. Taylor G., Lehrer M. S., Jensen P. J., Sun T. T., Lavker R. M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell. 2000;102:451–461. [PubMed: 10966107]
  339. Thompson L. H., Schild D. Recombinational DNA repair and human disease. Mutation Research. 2002;509:49–78. [PubMed: 12427531]
  340. Tomlinson I. P., Novelli M. R., Bodmer W. F. The mutation rate and cancer. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:14800–14803. [PMC free article: PMC26216] [PubMed: 8962135]
  341. Tonin P., Serova O., Lenoir G., Lynch H. T., Durocher F., Simard J., Morgan K., Narod S. BRCA1 mutations in Ashkenazi Jewish women. American Journal of Human Genetics. 1995;57:189. [PMC free article: PMC1801236] [PubMed: 7611288]
  342. Tsao J. L., Tavare S., Salovaara R., Jass J. R., Aaltonen L. A., Shibata D. Colorectal adenoma and cancer divergence. Evidence of multilineage progression. American Journal of Pathology. 1999;154:1815–1824. [PMC free article: PMC2222548] [PubMed: 10362806]
  343. Turker M. S. Autosomal mutation in somatic cells of the mouse. Mutagenesis. 2003;18:1–6. [PubMed: 12473728]
  344. Twort C. C., Twort J. M. Observations on the reaction of the skin to oils and tars. Journal of Hygiene. 1928;28:219–227. [PMC free article: PMC2167782] [PubMed: 20474996]
  345. Twort J. M., Twort C. C. Comparative activity of some carcinogenic hydrocarbons. American Journal of Cancer. 1939;35:80–85.
  346. Tyzzer E. E. Tumor immunity. Journal of Cancer Research. 1916;1:125–156.
  347. van Kempen L. C., Ruiter D. J., van Muijen G. N., Coussens L. M. The tumor microenvironment: a critical determinant of neoplastic evolution. European Journal of Cell Biology. 2003;82:539–548. [PubMed: 14703010]
  348. Vaupel, J. W. 2003. Post-darwinian longevity. In Carey, J. R., and Tuljapurkar, S., eds., Life Span: Evolutionary, Ecological, and Demographic Perspectives, pp. 258–269. Population Council, New York.
  349. Vaupel J. W., Carey J. R., Christensen K., Johnson T. E., Yashin A. I., Holm N. V., Iachine I. A., Kannisto V., Khazaeli A. A., Liedo P., Longo V. D., Zeng Y., Manton K. G., Curtsinger J. W. Biodemographic trajectories of longevity. Science. 1998;280:855–860. [PubMed: 9599158]
  350. Veale, A. M. O. 1965. Intestinal Polyposis, Vol. 40 of Eugenics Laboratory Memoirs. Cambridge University Press, Cambridge.
  351. Vijg J., Dolle M. E. Large genome rearrangements as a primary cause of aging. Mechanisms of Ageing and Development. 2002;123:907–915. [PubMed: 12044939]
  352. Vikkula M., Boon L. M., Mulliken J. B. Molecular genetics of vascular malformations. Matrix Biology. 2001;20:327–335. [PubMed: 11566267]
  353. Villadsen R. In search of a stem cell hierarchy in the human breast and its relevance to breast cancer evolution. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2005;113:903–921. [PubMed: 16480457]
  354. Vineis P., Alavanja M., Buffler P., Fontham E., Franceschi S., Gao Y. T., Gupta P. C., Hackshaw A., Matos E., Samet J., Sitas F., Smith J., Stayner L., Straif K., Thun M. J., Wichmann H. E., Wu A. H., Zaridze D., Peto R., Doll R. Tobacco and cancer: recent epidemiological evidence. Journal of the National Cancer Institute. 2004;96:99–106. [PubMed: 14734699]
  355. Vineis P., Pirastu R. Aromatic amines and cancer. Cancer Causes and Control. 1997;8:346–355. [PubMed: 9498898]
  356. Vogelstein, B., and Kinzler, K. W., eds. 2002. The Genetic Basis of Human Cancer (2nd edition). McGraw-Hill, New York.
  357. Wallace D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annual Review of Genetics. 2005;39:359–407. [PMC free article: PMC2821041] [PubMed: 16285865]
  358. Wang C., Fu M., Mani S., Wadler S., Senderowicz A. M., Pestell R. G. Histone acetylation and the cell-cycle in cancer. Frontiers in Bioscience. 2001;6:D610–629. [PubMed: 11282573]
  359. Watt F. M. Epidermal stem cells: markers, patterning and the control of stem cell fate. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 1998;353:831–837. [PMC free article: PMC1692275] [PubMed: 9684280]
  360. Watt F. M., Hogan B. L. Out of Eden: stem cells and their niches. Science. 2000;287:1427–1430. [PubMed: 10688781]
  361. Webster M. T., Rozycka M., Sara E., Davis E., Smalley M., Young N., Dale T. C., Wooster R. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes, Chromosomes and Cancer. 2000;28:443–453. [PubMed: 10862053]
  362. Weinberg, R. A. 2007. The Biology of Cancer. Garland Science, New York.
  363. Weiss K. M., Terwilliger J. D. How many diseases does it take to map a gene with SNPs? Nature Genetics. 2000;26:151–157. [PubMed: 11017069]
  364. Weiss L. Heterogeneity of cancer cell populations and metastasis. Cancer and Metastasis Reviews. 2000;19:351–379.
  365. Weissman I. L. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157–168. [PubMed: 10647940]
  366. Welcsh P. L., King M. C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Human Molecular Genetics. 2001;10:705–713. [PubMed: 11257103]
  367. Whittemore A. S. The age distribution of human cancer for carcinogenic exposures of varying intensity. American Journal of Epidemiology. 1977;106:418–432. [PubMed: 920729]
  368. Whittemore A. S. Effect of cigarette smoking in epidemiological studies of lung cancer. Statistics in Medicine. 1988;7:223–238. [PubMed: 3353605]
  369. Whittemore A. S., Keller J. B. Quantitative theories of carcinogenesis. SIAM Review. 1978;20:1–30.
  370. Wijnen J., Khan P. M., Vasen H. F., Menko F., van der Klift H., van den Broek M., van Leeuwen-Cornelisse I., Nagengast F., Meijers-Heijboer E. J., Lindhout D., Griffioen G., Cats A., Kleibeuker J., Varesco L., Bertario L., Bisgaard M. L., Mohr J., Kolodner R., Fodde R. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15–16. American Journal of Human Genetics. 1996;58:300–307. [PMC free article: PMC1914526] [PubMed: 8571956]
  371. Witkowski J. A. The inherited character of cancer—an historical survey. Cancer Cells. 1990;2:228–257. [PubMed: 2095763]
  372. Wright A., Charlesworth B., Rudan I., Carothers A., Campbell H. A polygenic basis for late-onset disease. Trends in Genetics. 2003;19:97–106. [PubMed: 12547519]
  373. Wu X., Gu J., Grossman H. B., Amos C. I., Etzel C., Huang M., Zhang Q., Millikan R. E., Lerner S., Dinney C. P., Spitz M. R. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. American Journal of Human Genetics. 2006;78:464–479. [PMC free article: PMC1380289] [PubMed: 16465622]
  374. Wunderlich V. Chromosomes and cancer: Theodor Boveri's predictions 100 years later. Journal of Molecular Medicine. 2002;80:545–548. [PubMed: 12226736]
  375. Yamada K. M. Cell biology: tumour jailbreak. Nature. 2003;424:889–890. [PubMed: 12931168]
  376. Yamashita Y. M., Jones D. L., Fuller M. T. Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome. Science. 2003;301:1547–1550. [PubMed: 12970569]
  377. Yatabe Y., Tavare S., Shibata D. Investigating stem cells in human colon by using methylation patterns. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:10839–10844. [PMC free article: PMC58561] [PubMed: 11517339]
  378. Young, J. L., Smith, M. A., Roffers, S. D., Liff, J. M., and Bunin, G. R. 1999. Retinoblastoma. In Ries, L. A. G., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T., Young, J. L., and Bunin, G. R., eds., Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, NIH Pub. No. 99–4649, pp. 73–78. National Cancer Institute, SEER Program, Bethesda, MD [http://seer​​/publications/childhood/].
  379. Yuan L. W., Keil R. L. Distance-independence of mitotic intrachromosomal recombination in Saccharomyces cerevisiae. Genetics. 1990;124:263–273. [PMC free article: PMC1203919] [PubMed: 2407612]
  380. Zaghloul N. A., Yan B., Moody S. A. Step-wise specification of retinal stem cells during normal embryogenesis. Biologie Cellulaire. 2005;97:321–337. [PubMed: 15836431]
  381. Zeise L., Wilson R., Crouch E. A. Dose-response relationships for carcinogens: a review. Environmental Health Perspectives. 1987;73:259–306. [PMC free article: PMC1474571] [PubMed: 3311725]
  382. Zheng Q. Progress of a half century in the study of the Luria-Delbruck distribution. Mathematical Biosciences. 1999;162:1–32. [PubMed: 10616278]
  383. Zheng Q. New algorithms for Luria-Delbruck fluctuation analysis. Mathematical Biosciences. 2005;196:198–214. [PubMed: 15950991]
Copyright © 2007, Steven A Frank.

This book, except where otherwise noted, is licensed under a Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Bookshelf ID: NBK6637


Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...